$ASMB
Assembly Biosciences, Inc
XNAS•Health Care•Pharmaceutical Preparations
$25.41
▲+0.28%+$0.070
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAssembly Biosciences, Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is ASMB up today? It is at $25.41 (+0.00%), and our scanner flagged it 52 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ASMB spikes, and full due diligence on ASMB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ASMB 52 times in the last 30 days. Create a free account to track $ASMB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ASMB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ASMB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAssembly Biosciences Reports Second Quarter 2026 Financial Results and Recent UpdatesReported – Completed $115 million gross financing to support advancement of pipeline programs through key development milestones –Reported – Cash runway projected into 2029, including first $75 million Gilead collaboration extension payment due in Q4 2026 –Reported Completed $115 million gross financing expected to extend funding beyond planned ABI-6250 Phase 2 studies in hepatitis delta virus (HDV) and cholestatic liver diseases, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bjorkquist Jeanette M Officer | Sold (automatic/other) | -29 | sold 0.2% | 15K | $674 at $23.25 | Jun 17, 26 |
Gilead Sciences, Inc. Beneficial Owner (10%) | Acquired (grant/award) | +472K 2.3% of company | added 10% | 4.98M | $12.5M at $26.50 | May 26, 26 |
Bjorkquist Jeanette M Officer | Sold (automatic/other) | -328 | sold 2.9% | 11K | $9K at $26.65 | Mar 30, 26 |
White Nicole S Officer | Sold (automatic/other) | -197 | sold 0.5% | 37K | $5K at $26.65 | Mar 30, 26 |
Okazaki Jason A Officer | Acquired (grant/award) | +94K 0.5% of company | added 100% | 112K | n/a | Mar 29, 26 |
Delaney William E Iv Officer | Acquired (grant/award) | +26K 0.1% of company | added 100% | 46K | n/a | Mar 29, 26 |
Gaggar Anuj Officer | Acquired (grant/award) | +26K 0.1% of company | added 100% | 28K | n/a | Mar 29, 26 |
White Nicole S Officer | Acquired (grant/award) | +26K 0.1% of company | added 100% | 38K | n/a | Mar 29, 26 |
White Nicole S Officer | Acquired (grant/award) | +14K 0.07% of company | added 41% | 48K | n/a | Mar 29, 26 |
Bjorkquist Jeanette M Officer | Acquired (grant/award) | +7K 0.03% of company | added 100% | 11K | n/a | Mar 29, 26 |
Bjorkquist Jeanette M Officer | Acquired (grant/award) | +4K 0.02% of company | added 32% | 15K | n/a | Mar 29, 26 |
Okazaki Jason A Officer | Acquired (grant/award) | +51K 0.2% of company | added 45% | 163K | n/a | Mar 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ASMB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ASMB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ASMB last traded at $25.41, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Assembly Biosciences, Inc (ASMB) is next expected to report earnings on Monday, November 9, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ASMB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ASMB 52 times in the last 30 days.
ASMB (Assembly Biosciences, Inc) trades on XNAS, with a market cap of about $519M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ASMB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ASMB discussion
Sign in to ask a question or join the discussion.